Rapid antibody development yields possible treatment for yellow fever
The experimental drug has shown promise in early-stage clinical trials conducted in Singapore.
The experimental drug has shown promise in early-stage clinical trials conducted in Singapore.
Disruption of condensates in the neurodevelopmental disorder provides insights into how cells compartmentalize chromosomes, as well as new potential therapies.
Processing vocal recordings of infected but asymptomatic people reveals potential indicators of Covid-19.
Using UV-C light, the system can disinfect a warehouse floor in half an hour — and could one day be employed in grocery stores, schools, and other spaces.
Massachusetts Emergency Response Team helps manufacturers produce personal protective equipment and other medical devices for health care workers.
Knocking out the immune cytokine IL-6 exacerbates symptoms in HD model mice, affects neural connection genes.
Using engineered binder proteins to detect viral proteins or antibodies rather than RNA, new tests may overcome current challenges in testing for SARS-CoV-2 virus.
Junli Hao's efforts aid procurement of face masks and respirators for first responders.
The MIT-IBM Watson AI Lab is funding 10 research projects aimed at addressing the health and economic consequences of the pandemic.
Hadley Sikes designs simple-to-use diagnostic devices that could benefit patients around the world.
Suggested design could make it easier to divide air flow for Covid-19 patients in emergencies when no other options are available.
Paper co-authored by MIT economist proposes a new way to handle medical shortages during the Covid-19 crisis.
Lincoln Laboratory joins MIT and others in testing N95 and similar, imported respirator masks to check how well they keep out particles and blood.
Differently shaped RNA molecules allow HIV to express different genes from the same RNA sequence.
MIT economist Pierre Azoulay outlines a roadmap for scientific success against the virus.